XML 174 R38.htm IDEA: XBRL DOCUMENT
v3.24.1.1.u2

SHARE CAPITAL, WARRANTS AND OPTIONS (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
SHARE CAPITAL, WARRANTS AND OPTIONS |
Schedule of assumptions used to calculate fair value of the warrants in connection with financing transactions | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | February 24, 2023 |  | June 28, 2023 |
Expected dividend yield |  | ​ | 0 | % | ​ | 0 | %
Stock price | ​ | $ | 1.73 | ​ | $ | 1.35 | ​
Expected share price volatility | ​ |  | 77.52 | % |  | 92.06 | %
Risk free interest rate | ​ |  | 4.28 | % |  | 4.13 | %
Expected life of warrant | ​ |  | 2 | years |  | 3 | years
Schedule of common share purchase warrant activity and outstanding common share purchase warrants exercisable to acquire common shares | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | December 31, 2023 |  | December 31, 2022
​ |  | ​ |  | Weighted |  | ​ |  | Weighted
​ | ​ | ​ | ​ | Average | ​ | ​ | ​ | Average
​ | ​ | Number | ​ | Exercise Price | ​ | Number | ​ | Exercise Price
​ | ​ | Outstanding | ​ | ($) | ​ | Outstanding | ​ | ($)
Outstanding, beginning of the year | ​ | 1,098,786 | ​ | 1.96 | ​ | — | ​ | —
Adjustment pursuant to the RTO | ​ | ​ | ​ | ​ | ​ | 2,228,340 | ​ | 1.11
Issued | ​ | 6,595,448 | ​ | 1.46 | ​ | 119,229 | ​ | 2.04
Exercised | ​ | (100,000) | ​ | 1.75 | ​ | (1,236,408) | ​ | 0.46
Cancelled/expired | ​ | (703,135) | ​ | 1.80 | ​ | (12,375) | ​ | 0.45
Outstanding, end of the year | ​ | 6,891,099 | ​ | 1.50 | ​ | 1,098,786 | ​ | 1.96
​ At December 31, 2023, the Company had outstanding common share purchase warrants exercisable to acquire common shares of the Company as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | Exercise Price |  | Weighted Average remaining
Warrants Outstanding | ​ | Expiry Date | ​ | ($) | ​ | contractual life (years)
295,651 | ​ | August 3, 2024 |  | 2.40 |  | 0.02
221,448 | ​ | February 24, 2025 |  | 1.75 |  | 0.04
350,000 | ​ | March 17, 2024 |  | 1.75 |  | 0.01
5,324,000 | ​ | June 28, 2026 |  | 1.44 |  | 1.93
700,000 | ​ | June 28, 2026 |  | 1.44 |  | 0.25
6,891,099 | ​ | ​ |  |  |  | 2.25
​ At December 31, 2022, the Company had outstanding common share purchase warrants exercisable to acquire common shares of the Company as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | Exercise Price |  | Weighted Average remaining
Warrants Outstanding | ​ | Expiry Date | ​ | ($) | ​ | contractual life (years)
683,905 | ​ | April 16, 2023 |  | 1.75 |  | 0.18
295,652 | ​ | August 3, 2024 |  | 2.40 |  | 0.43
119,229 | ​ | November 25, 2023 |  | 2.04 |  | 0.10
1,098,786 | ​ | ​ |  |  |  | 0.71
Schedule of option activity | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | December 31, 2023 |  | December 31, 2022
​ |  | ​ |  | Weighted |  | ​ |  | Weighted
​ | ​ | ​ | ​ | Average | ​ | ​ | ​ | Average
​ | ​ | Number | ​ | Exercise Price | ​ | Number | ​ | Exercise Price
​ | ​ | Outstanding | ​ | ($) | ​ | Outstanding | ​ | ($)
Outstanding, beginning of the year | ​ | 10,407,044 | ​ | 1.10 | ​ | 2,995,794 | ​ | 1.33
Issued | ​ | 3,833,277 | ​ | 1.75 | ​ | 8,827,250 | ​ | 1.16
Exercised | ​ | (488,900) | ​ | 0.49 | ​ | (1,416,000) | ​ | 0.46
Cancelled | ​ | (263,500) | ​ | 2.40 | ​ | — | ​ | —
Outstanding, end of the year | ​ | 13,487,921 | ​ | 1.39 | ​ | 10,407,044 | ​ | 1.10
Schedule of assumptions used to calculate the fair value of stock options granted | ​
​ | ​ | ​ | ​ | ​ | ​
​ |  | December 31, 2023 |  | December 31, 2022 |
Expected dividend yield |  | 0 | % | 0 | %
Expected forfeiture rate | ​ | 0 | % | 0 | %
Expected share price volatility |  | 87.92 | % | 125.83%-129.48 | %
Risk free interest rate |  | 4.28-4.68 | % | 0.42%-2.85 | %
Expected life of options |  | 3-4 | years | 4.16-5 | years
Schedule of details of options outstanding | Details of options outstanding as at December 31, 2023 are as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | ​ |  | ​ |  | Weighted average
Options | ​ | Options | ​ | Expiry | ​ | Exercise | ​ | remaining contractual life
Outstanding | ​ | Exercisable | ​ | Date | ​ | Price ($) | ​ | (years)
780,000 |  | 780,000 | ​ | February 24, 2025 |  | 0.80 |  | 0.07
240,000 |  | 240,000 | ​ | August 19, 2025 |  | 0.45 |  | 0.03
3,320,100 |  | 3,320,000 | ​ | January 26, 2026 |  | 0.39 |  | 0.50
495,000 |  | 495,000 | ​ | February 25, 2026 |  | 1.60 |  | 0.08
1,343,850 |  | 1,343,850 | ​ | September 29, 2026 |  | 0.91 |  | 0.27
998,794 |  | 998,794 | ​ | October 25, 2026 |  | 2.00 |  | 0.20
2,476,900 |  | 2,476,900 | ​ | January 20, 2027 |  | 2.40 |  | 0.56
3,833,277 |  | — | ​ | August 8, 2028 |  | 1.75 |  | 1.31
13,487,921 |  | 9,654,544 | ​ | ​ |  |  |  | 3.04
​ Details of options outstanding as at December 31, 2022 are as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | ​ |  | ​ |  | Weighted average
Options | ​ | Options | ​ | Expiry | ​ | Exercise | ​ | remaining contractual life
Outstanding | ​ | Exercisable | ​ | Date | ​ | Price ($) |  | ( years)
900,000 |  | 900,000 | ​ | February 24, 2025 |  | 0.80 |  | 0.19
240,000 |  | 240,000 | ​ | August 19, 2025 |  | 0.45 |  | 0.06
3,689,000 |  | 3,689,000 | ​ | January 26, 2026 |  | 0.39 |  | 1.09
495,000 |  | 495,000 | ​ | February 25, 2026 |  | 1.60 |  | 0.15
1,343,850 |  | 1,343,850 | ​ | September 29, 2026 |  | 0.91 |  | 0.48
998,794 |  | 998,794 | ​ | October 25, 2026 |  | 2.00 |  | 0.37
2,740,400 |  | 2,740,400 | ​ | January 20, 2027 |  | 2.62 |  | 1.07
10,407,044 |  | 10,407,044 | ​ | ​ |  |  |  | 3.41
​
Schedule of DSU granted | ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Number |  | Market Price 1 |  | Fair Value
​ | ​ | Outstanding | ​ | ($) | ​ | ($)
DSUs outstanding at December 31, 2022 |  | 200,000 |  | 1.49 |  | 298,000
DSUs granted during the year2 |  | 600,951 |  | 1.33 |  | 798,122
DSUs redeemed during the year |  | (69,976) |  | 1.19 |  | (83,527)
Fair value adjustment |  | — |  | ​ |  | (128,114)
DSUs outstanding at December 31, 2023 |  | 730,975 |  | 1.21 |  | 884,481
​
1. | According to the DSU plan, Market Price is the volume weighted average price on the TSXV for the last five trading days immediately preceding the grant date.
2. | DSUs were granted on March 31, Jun 30, Sept 30 and December 31, 2023. The market price of $1.33 represented the weighted average price for those grants.
​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Number |  | Market Price |  | Fair Value
​ | ​ | Outstanding | ​ | ($) | ​ | ($)
DSUs outstanding at December 31, 2021 |  | — |  | — |  | —
DSUs granted during the year |  | 200,000 |  | 1.49 |  | 298,000
DSUs outstanding at December 31, 2022 |  | 200,000 |  | 1.49 |  | 298,000

X
- Definition The tabular disclosure of fair value assumptions used to calculate the fair value of warrants. + References No definition available. + Details
Name: | pnrlf_ScheduleOfStockholdersEquityNoteWarrantsOrRightsValuationAssumptionsTableTextBlock
Namespace Prefix: | pnrlf_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of activity for outstanding award under share-based payment arrangement excluding share and unit options and nonvested award. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the change in stock options. + References No definition available. + Details
Name: | us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration